Key Record Dates
| ClinicalTrials.gov Identifier: | NCT06035744 |
|---|---|
| Brief Title: | CLN-617 Alone and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors |
| First Submitted : | August 31, 2023 |
| First Submitted that Met QC Criteria : | September 6, 2023 |
| First Posted : | September 13, 2023 |
| Last Update Submitted that Met QC Criteria : | April 30, 2024 |
| Last Update Posted : | May 2, 2024 |